Table 2 The characteristics of the included studies for IL-10 −819 C/T polymorphism and urologic cancer risk
References | Country | Ethnicity | Case | Control | P value HWE | NOS score | ||||
|---|---|---|---|---|---|---|---|---|---|---|
n | Genotypes CC/CT/TT | Alleles C/T (%) | n | Genotypes CC/CT/TT | Alleles C/T (%) | |||||
Prostate cancer | ||||||||||
India | Asian | 291 | 68/131/92 | 45.9/54.1 | 291 | 60/151/80 | 46.6/53.4 | 0.466 | 8 | |
Faupel-Badger et al. (2008) | USA | Caucasian | 507 | 283/184/40 | 74.0/26.0 | 384 | 244/122/18 | 79.4/20.6 | 0.585 | 7 |
Kesarwani et al. (2009) | India | Asian | 159 | 52/68/39 | 54.1/45.9 | 259 | 65/125/69 | 49.2/50.8 | 0.579 | 8 |
Liu et al. (2010) | China | Asian | 262 | 34/108/120 | 33.6/66.4 | 270 | 28/110/132 | 30.7/69.3 | 0.477 | 8 |
Michaud et al. (2006) | USA | Mixed | 1246 | 716/447/83 | 75.4/24.6 | 1762 | 964/659/139 | 73.4/26.6 | 0.078 | 8 |
VanCleave et al. (2010) | USA | African | 191 | 76/85/30 | 62.0/38.0 | 635 | 246/278/111 | 60.6/39.4 | 0.037 | 8 |
Winchester et al. (2015) | USA | Mixed | 611 | 372/206/33 | 77.7/22.3 | 659 | 408/217/34 | 78.4/21.6 | 0.464 | 8 |
Zabaleta et al. (2008) | USA | Mixed | 526 | 308/180/38 | 75.7/24.3 | 494 | 249/204/41 | 71.1/28.9 | 0.931 | 8 |
Renal cancer | ||||||||||
Basturk et al. (2005) | Turkey | Caucasian | 29 | 13/14/2 | 69.0/31.0 | 50 | 24/19/7 | 67.0/33.0 | 0.320 | 7 |
Cozar et al. (2007) | Spain | Caucasian | 127 | 81/37/9 | 78.3/21.7 | 175 | 98/63/14 | 74.0/26.0 | 0.394 | 8 |
Chang et al. (2016) | Taiwan | Asian | 92 | 4/26/62 | 18.5/81.5 | 580 | 61/209/310 | 28.5/71.5 | 0.005 | 8 |
Bladder cancer | ||||||||||
Ahirwar et al. (2009) | India | Asian | 214 | 46/103/65 | 45.6/54.4 | 385 | 115/165/105 | 51.3/48.7 | 0.005 | 8 |
Chen et al. (2013) | China | Asian | 400 | 42/140/218 | 28.0/72.0 | 400 | 64/168/168 | 37.0/63.0 | 0.047 | 8 |